Catheter Precision, Inc.
A medical device company that develops technology for cardiac electrophysiology, including the VIVO system used to help locate the source of abnormal heart rhythms before procedures. The company's tools are used by doctors in hospitals to guide treatment of conditions like ventricular tachycardia. It was formed through a merger of earlier cardiac-mapping ventures and is based in the United States.
Bought 52.3K
Sold 2.7K
Sold 8.1K
Sold 3
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Jenkins David AChairman of the Board and CEO · 12 transactions | — | 48.5K | — | 52.3K | — |
| Jackson Andrew C.CFO · 3 transactions | -42.2% | 21.7Kas of May 2022 | — | — | 2.7K |
| Meline SusanneDirector · 1 transaction | — | 3.4Kas of Mar 2023 | — | — | — |
| McGuire Jonathan WillCEO & Secretary, Director · 4 transactions | -99% | 1.1Kas of Nov 2022 | — | — | 8.1K |
| Colombatto Martin JDirector · 1 transaction | -99.8% | 57as of Jan 2025 | — | — | 3 |
| Caruso James JosephDirector · 2 transactions | — | 50 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: +41.4K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.